This study was supported by NIH grants R01HL091020, R01HL093723, R01AI077343, and R01GM096187.

1. RBCs isolation from the whole blood
<ol>
 <li>Prepare EAS-45 solutions. Weigh up all ingredients from Table I and dissolve in 100-200ml of DI water. Add water to make 1000ml solution and adjust pH to 8.0. Filter and aliquot by 50ml. Freeze at -20&deg;C for storage.</li>
</ol>
Note: Step 1.2 should be performed by a trained medical professional such as a nurse, with an Institutional Review Board approved protocol.
<ol start="2">
 <li>Draw 3-5ml of blood from the median cubital vein into a 10ml tube containing EDTA and gently mix the blood with EDTA immediately and thoroughly to avoid clotting.</li>
 <li>Process blood sample as soon as possible. All the following steps except centrifugation should be done under the hood to keep the preparation sterile. Transfer the blood to a 50ml centrifuge tube, add 10ml of cold and sterile Histopaque 1077 and centrifuge for 5min @ 1000rpm, 4&deg;C. Repeat twice.</li>
 <li>Add 10ml cold and sterile PBS, centrifuge for 5min @ 1000rpm, 4&deg;C. Remove the supernatant. Repeat 4 times (Total of 5 times).</li>
 <li>Wash with sterile EAS-45 (5min @ 1000rpm, 4&deg;C) twice. During last washing move RBCs into a new sterile 15ml tube.</li>
 <li>Resuspend RBCs in10ml EAS-45.</li>
</ol>
2. RBCs biotinylation
<ol>
 <li>Take the tube with RBCs from step 1. Remove all supernatant after centrifuging for 5min @ 1000rpm, 4&deg;C. Put 10&mu;l of RBCs pellet to each of several vials and add corresponding amount of PBS to each vial (see Table II for example of preparation of six different RBCs biotinylation concentrations).</li>
 <li>Make fresh Biotin-X-NHS/DMF 1:10, 1:100 dilutions according to Table II.</li>
 <li>Add 10&mu;l of 0.1M borate buffer to each vial.</li>
 <li>Add calculated amount of biotin solution to each vial (see Table II as example) and vortex immediately.</li>
 <li>Place each RBC vial inside a 50ml conical tube and incubate on rotator for 30min at room temperature.</li>
 <li>Wash each vial 3 times with 800&mu;l of EAS-45 for 2min @ 2000rpm.</li>
 <li>Add 100&mu;l of EAS-45 to each vial and store at 4&deg;C. In each 1&mu;l of the final solution now should be &tilde;1mln of RBCs.</li>
</ol>
3. Functionalizing the biotin-linked ligands* on RBCs
<ol>
 <li>Prepare 2mg/ml streptavidin solution according to manufacturer's instructions. Aliqouted solution may be stored at -20&deg;C.</li>
 <li>Mix an equal amount of RBCs from step 2.7 (10&mu;l) with streptavidin solution, vortex immediately and incubate on rotator for 30min at 4&deg;C.</li>
 <li>Wash 3 times with 500&mu;l of EAS-45 for 2min @ 2000rpm. Add 15&mu;l EAS-45/ 1% BSA for storage.</li>
 <li>Mix equal amount of RBCs from step 3.3 (10&mu;l) with 20&mu;g/ml ligand solution, vortex immediately and incubate on rotator for 30min at room temperature.</li>
 <li>Wash two times with 500&mu;l of EAS-45/ 1% BSA for 2min @ 2000rpm. Add 15&mu;l of EAS-45/1% BSA for storage.</li>
</ol>
*If your protein has no biotin link you can use one of the commercially available kits for protein biotinylation (for example, Thermo Scientific # 21955 EZ-Link Micro NHS-PEG4-Biotinylation Kit) or use biotinylated capturing antibodies as an intermediate step as shown in the video.
4. Quantification of receptor and ligand densities
<ol>
 <li>Incubate ligand-coated RBCs from step 3 and, in a different vial, receptor-bearing cells with saturating concentrations of respective mAbs for 30min at room temperature. Incubate in separate vials cells with irrelevant isotype-matched antibodies for control. If the primary antibodies are not fluorescently labeled, incubate with fluorescently-conjugated secondary antibodies according to manufacturer's instructions.</li>
 <li>Analyze samples prepared in step 4.1 by flow cytometery with corresponding fluorescent calibration beads. Calculate the densities as shown in Fig. 1.</li>
</ol>
5. Preparation for micropipette and cell chamber
<ol>
 <li>Pull micropipettes from capillary tubes using PN-30 Narishige' Magnetic Glass Microelectrode Horizontal Puller or Sutter Instruments Micropipette Puller.</li>
 <li>Use micromanipulator with microforge to adjust the tip of the pulled micropipette to a desired size (usually the required diameter ranges from 1-5&mu;m depending on the size of the cells to be used in the study).</li>
 <li>Prepare the cell chamber by cutting Microscope Cover Glass to the desired size. Seal the chamber using Mineral Oil from both sides to avoid medium evaporation to change the osmolarity during the experiment.</li>
 <li>Add the receptor- and ligand-bearing cells to the chamber.</li>
</ol>
6. Micropipette adhesion frequency assay
<ol>
 <li>Aspirate the interacting cells by respective pipettes and use computer-programmed piezoelectric translator to drive the RBC in and out of contact with the other cell with controlled contact area and time. Detect adhesion events by observing RBC elongation upon cell separation.</li>
 <li>Repeat the contact-retraction cycle 50-100 times for a given contact time. Record the observed adhesion events by adding "1" for adhesion or "0" for no adhesion in a column of Excel spreadsheet. You may use a recording device, e.g., digital media or videotape, for the microscopic images.</li>
 <li>Record the adhesion frequency versus contact time curve using at least three different cell pairs for each contact time to obtain a mean and SEM.</li>
 <li>Record the nonspecific binding curve for control by using RBCs coated with irrelevant ligands (e.g. BSA) and/or blocking the ligands or receptors using their specific functional blockade mAbs. Specific adhesion frequency at each contact time point can be calculated by removal of the nonspecific adhesion frequency1.</li>
</ol>
7. Data analysis
<ol>
 <li>Fit the specific adhesion frequency Pa versus contact time t data by a probabilistic model (Equation 1) that describes a second-order forward and first-order reverse, single-step interaction between a single species of receptors and a single species of ligands1: 
 <img alt="Equation 1" src="/files/ftp_upload/3519/3519eq1.jpg" /> 
 where Ka is the 2D effective binding affinity, koff is the off-rate, mr and ml are the respective receptor and ligand densities measured in step 4, and Ac is the contact area. The curve-fit has two parameters, AcKa and koff, as Ac and Ka are lumped together and called collectively as effective 2D affinity. Its product with the off-rate is the effective 2D on-rate: Ackon = AcKa x koff. 
 The specific adhesion frequency Pa is calculated by subtraction of the nonspecific adhesion fraction (Pnonspecific) from the total measured adhesion (Pmeasured)1,21: 
 <img alt="Equation 2" src="/files/ftp_upload/3519/3519eq2.jpg" /></li>
</ol>
8. Representative Results:
<img alt="Figure 1" src="/files/ftp_upload/3519/3519fig1.jpg" /> 
Figure 1 Determination of integrin &alpha;L&beta;2 site density on neutrophils. Neutrophils were first incubated with 1&mu;g/ml of E-selectin-Ig for 10min to match the experimental condition used in Figures 3,4 or without E-selectin-Ig, and then with saturating concentrations (10&mu;g/ml) of PE-conjugated anti-human CD11a mAb (Clone HI111, see Table of specific reagents and equipment) or irrelevant mouse IgG1 for control, washed, and analyzed immediately. Samples were read on BD LSR flow cytometer with standard QuantiBRITE PE calibration beads. Panel A shows fluorescence histograms of calibration beads (pink) together with those of E-selectin-Ig treated (blue color) or untreated cells (green color). Specific CD11a mAb staining is shown in solid curves and irrelevant isotype-matched control antibody staining is shown in dotted curves. Cells treated with E-selectin-Ig (presence in all washing steps and in FACS buffer) did not affect the CD11a density as seen from the comparison with untreated cells. Panel B shows the process of density quantification. Log10 was calculated for the mean fluorescent intensity (FI) of each peak value of four calibration bead histograms from Panel A (pink circles) and for the lot-specific PE molecules per bead (from the manufacturer). A linear regression of Log10 PE molecules per bead against Log10 fluorescence was plotted. For E-selectin treated cells the Log10 FI (y) values equal 3.99 (blue solid circle) and 2.23 (blue open circle) for specific mAb and control antibody, respectivly. We solved the linear equation for x (values are plotted as green and blue circles on Panel B). x = Log10 PE/cell and, as PE:mAb ratio was 1:1, the total number of &alpha;L&beta;2 on neutrophils was calculated as 9587. Surface density was calculated to be 43 molecules/&mu;m2, using 8.4&mu;m as the neutrophil diameter22. Density of ICAM-1 was similarly measured by flow cytometery using PE-anti-human CD54 mAb, which equaled 65 mol/&mu;m2.
<img alt="Figure 2" src="/files/ftp_upload/3519/3519fig2.jpg" /> 
Figure 2 Micropipette system schematics. Our micropipette system was assembled in house and consists of three subsystems: an imaging subsystem to allow one to observe, record and analyze movements of the micropipette-aspirated cell; a micromanipulation subsystem to enable one to select the cells from the cell chamber, and a pressure subsystem to allow one to aspirate the cells into micropipettes. The central piece of the imaging subsystem is inverted microscope (Olympus IMT-2 IMT2) with a 100x oil immersion 1.25 N.A. objective. The image is sent to a video cassette recorder through a charge couple device (CCD) camera. A video timer is coupled to the system to keep track of time. Each micropipette can be manipulated by a mechanical drive mounted on the microscope and finely positioned with a three-axis hydraulic micromanipulator. Mechanical manipulators from Newport could be used as well. One of the micropipette holders is mounted on a piezoelectric translator, the driver of which is controlled by a computer LabView code (available upon request) and the signal translates through a DAQ board via a voltage amplifier (homemade) to the piezo actuator. This allows one to move the pipette precisely and repeatably in an adhesion test cycle. The pressure regulation subsystem is used to control suction during the experiment. A hydraulic line connects the micropipette holder to a fluid reservoir. A fine mechanical positioner allows the height of the reservoir to be precisely manipulated.
Micropipettes are generated using KIMAX melting point borosilicate glass capillary tubes (with outside diameter of 1.0&plusmn;0.07 mm and an inside diameter of 0.7&plusmn;0.07 mm. First, the micropipettes from capillary tubes are pulled using PN-30 Narishige' Magnetic Glass Microelectrode Horizontal Puller (Sutter Instruments Micropipette Puller is another puller option). Second, Microforge system (built in house) is used to cut the micropipettes to desired size opening. Commercial models of Microforge systems are available as well.
To avoid vibration of the micropipettes during the experiment, the microscope, along with the micromanipulators, is placed on an air suspension table.
<img alt="Figure 3" src="/files/ftp_upload/3519/3519fig3.jpg" /> 
Figure 3 Running adhesion frequency Fi for specific (A) and nonspecific (B) binding at 1s (red) and 10s (blue) contact times measured from repeated adhesion test cycles between RBCs coated with ICAM-1 (A) or hIgG (B) with human neutrophils expressing integrin &alpha;L&beta;2. Fi = (X1 + X2 +&hellip;+ Xi)/i (1 &le;i &le; n), where i is the test cycle index, Xi equals "1" (adhesion) or "0" (no adhesion). Fn (n=50) was used as the best estimate for adhesion probability.
<img alt="Figure 4" src="/files/ftp_upload/3519/3519fig4.jpg" /> 
Figure 4 Kinetics of ICAM-1 binding to neutrophil integrin &alpha;L&beta;2 (<img alt="Square" src="/files/ftp_upload/3519/3519sq1.jpg" />). Adhesion probability measured as shown in Figure 3 for three cell pairs at each contact time is averaged and plotted versus contact time. The chamber medium was HBSS with 1mM each of Ca2+ and Mg2+ plus 1&mu;g/ml of dimeric E-selectin-Ig to upregulate &alpha;L&beta;2 binding. To capture ICAM-1-Ig on RBCs, an intermediate step was added to incubate RBCs with 10&mu;g/ml capture antibody (biotinylated goat-anti-human Fc antibody, eBioscience) after the streptavidin incubation step. To control for nonspecific binding two different conditions were used: 1) RBCs coated with the anti-human-Fc capture antibody and incubated with human IgG instead of ICAM-1-Ig (O) and 2) neutrophils binding to RBCs not coated with the capture antibody (&Delta;). 10&mu;g/ml human IgG was added to the medium to minimize binding of E-selectin-Ig in solution to the capture antibody on the RBC surface. Nonspecific binding recorded as human IgG control curve was used to obtain a specific adhesion probability curve (<img alt="Square" src="/files/ftp_upload/3519/3519sq2.jpg" />) using Eq. 2. Fitting specific adhesion probability curve with Eq. 1 (solid line) returned effective binding affinity AcKa = 1.4&bull;10-4 &mu;m4 and koff = 0.3 s-1.
<table border="1">
 <tbody>
 <tr>
 <th>
 Reagent</th>
 <th>
 MW (g/mol)</th>
 <th>
 Concentration (mM)</th>
 <th>
 Amount (g)</th>
 </tr>
 <tr>
 <td>Adenine</td>
 <td>135.13</td>
 <td>2</td>
 <td>0.27</td>
 </tr>
 <tr>
 <td>D-glucose (dextrose)</td>
 <td>180.16</td>
 <td>110</td>
 <td>19.82</td>
 </tr>
 <tr>
 <td>D-Mannitol</td>
 <td>182.17</td>
 <td>55</td>
 <td>10.02</td>
 </tr>
 <tr>
 <td>Sodium Chloride (NaCl)</td>
 <td>58.44</td>
 <td>50</td>
 <td>2.92</td>
 </tr>
 <tr>
 <td>Sodium Phosphate, Dibasic (Na HPO )</td>
 <td>141.95</td>
 <td>20</td>
 <td>2.84</td>
 </tr>
 <tr>
 <td>L-glutamine</td>
 <td>146.15</td>
 <td>10</td>
 <td>1.46</td>
 </tr>
 </tbody>
</table>
Table 1. EAS-45 buffer preparation (1L).
<table border="1">
 <tbody>
 <tr>
 <td>25 mg biotin-XHS in 550 &mu;l of DMF</td>
 <td>0.1M biotin solution</td>
 </tr>
 <tr>
 <td>1:10 dilution of 0.1 biotin w/DMF</td>
 <td>0.01M biotin solution</td>
 </tr>
 <tr>
 <td>1:100 dilution of 0.1 biotin w/ DMF</td>
 <td>0.001M biotin solution</td>
 </tr>
 </tbody>
</table>
Table 2. Preparation of the biotin solution.
<table border="1">
 <tbody>
 <tr>
 <th>
 biotin final concentration (&mu;M)</th>
 <th>
 4</th>
 <th>
 10</th>
 <th>
 20</th>
 <th>
 50</th>
 <th>
 100</th>
 <th>
 160</th>
 </tr>
 <tr>
 <td>RBCs pellet stock (&mu;l)</td>
 <td>10</td>
 <td>10</td>
 <td>10</td>
 <td>10</td>
 <td>10</td>
 <td>10</td>
 </tr>
 <tr>
 <td>1x PBS (&mu;l)</td>
 <td>179.2</td>
 <td>178</td>
 <td>176</td>
 <td>179</td>
 <td>178</td>
 <td>176.8</td>
 </tr>
 <tr>
 <td>0.1M borate buffer (&mu;l)</td>
 <td>10</td>
 <td>10</td>
 <td>10</td>
 <td>10</td>
 <td>10</td>
 <td>10</td>
 </tr>
 <tr>
 <td>0.01M biotin solution (&mu;l)</td>
 <td>&nbsp;</td>
 <td>&nbsp;</td>
 <td>&nbsp;</td>
 <td>1</td>
 <td>2</td>
 <td>3.2</td>
 </tr>
 <tr>
 <td>0.001M biotin solution (&mu;l)</td>
 <td>0.8</td>
 <td>2</td>
 <td>4</td>
 <td>&nbsp;</td>
 <td>&nbsp;</td>
 <td>&nbsp;</td>
 </tr>
 </tbody>
</table>
Table 3. Biotinylation of RBCs.

<ol>
	<li>Chesla, S. E., Selvaraj, P., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Measuring+two-dimensional+receptor-ligand+binding+kinetics+by+micropipette.">Measuring two-dimensional receptor-ligand binding kinetics by micropipette.</a> Biophys. J. 75, 1553-1572 (1998).</li><li>Chesla, S. E., Li, P., Nagarajan, S., Selvaraj, P., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+membrane+anchor+influences+ligand+binding+two-dimensional+kinetic+rates+and+three-dimensional+affinity+of+FcgammaRIII+(CD16).">The membrane anchor influences ligand binding two-dimensional kinetic rates and three-dimensional affinity of FcgammaRIII (CD16).</a> J. Biol. Chem. 275, 10235-10246 (2000).</li><li>Williams, T. E., Nagarajan, S., Selvaraj, P., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Concurrent+and+independent+binding+of+Fcgamma+receptors+IIa+and+IIIb+to+surface-bound+IgG.">Concurrent and independent binding of Fcgamma receptors IIa and IIIb to surface-bound IgG.</a> Biophys. J. 79, 1867-1875 (2000).</li><li>Williams, T. E., Selvaraj, P., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Concurrent+binding+to+multiple+ligands:+kinetic+rates+of+CD16b+for+membrane-bound+IgG1+and+IgG2.">Concurrent binding to multiple ligands: kinetic rates of CD16b for membrane-bound IgG1 and IgG2.</a> Biophys. J. 79, 1858-1866 (2000).</li><li>Williams, T. E., Nagarajan, S., Selvaraj, P., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Quantifying+the+impact+of+membrane+microtopology+on+effective+two-dimensional+affinity.">Quantifying the impact of membrane microtopology on effective two-dimensional affinity.</a> J. Biol. Chem. 276, 13283-13288 (2001).</li><li>Huang, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Quantifying+the+effects+of+molecular+orientation+and+length+on+two-dimensional+receptor-ligand+binding+kinetics.">Quantifying the effects of molecular orientation and length on two-dimensional receptor-ligand binding kinetics.</a> J. Biol. Chem. 279, 44915-44923 (2004).</li><li>Long, M., Zhao, H., Huang, K. S., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Kinetic+measurements+of+cell+surface+E-selectin/carbohydrate+ligand+interactions.">Kinetic measurements of cell surface E-selectin/carbohydrate ligand interactions.</a> Ann. Biomed. Eng. 29, 935-946 (2001).</li><li>Chen, W., Evans, E. A., McEver, R. P., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Monitoring+receptor-ligand+interactions+between+surfaces+by+thermal+fluctuations.">Monitoring receptor-ligand interactions between surfaces by thermal fluctuations.</a> Biophys. J. 94, 694-701 (2008).</li><li>Wu, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Impact+of+carrier+stiffness+and+microtopology+on+two-dimensional+kinetics+of+P-selectin+and+P-selectin+glycoprotein+ligand-1+(PSGL-1)+interactions.">Impact of carrier stiffness and microtopology on two-dimensional kinetics of P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) interactions.</a> J. Biol. Chem. 282, 9846-9854 (2007).</li><li>Waugh, R. E., Lomakina, E. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Active+site+formation,+not+bond+kinetics,+limits+adhesion+rate+between+human+neutrophils+and+immobilized+vascular+cell+adhesion+molecule+1.">Active site formation, not bond kinetics, limits adhesion rate between human neutrophils and immobilized vascular cell adhesion molecule 1.</a> Biophys. J. 96, 268-275 (2009).</li><li>Zhang, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Two-dimensional+kinetics+regulation+of+alphaLbeta2-ICAM-1+interaction+by+conformational+changes+of+the+alphaL-inserted+domain.">Two-dimensional kinetics regulation of alphaLbeta2-ICAM-1 interaction by conformational changes of the alphaL-inserted domain.</a> J. Biol. Chem. 280, 42207-42218 (2005).</li><li>Lomakina, E. B., Waugh, R. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Adhesion+between+human+neutrophils+and+immobilized+endothelial+ligand+vascular+cell+adhesion+molecule+1:+divalent+ion+effects.">Adhesion between human neutrophils and immobilized endothelial ligand vascular cell adhesion molecule 1: divalent ion effects.</a> Biophys. J. 96, 276-284 (2009).</li><li>Chen, W., Lou, J., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Forcing+switch+from+short-+to+intermediate-+and+long-lived+states+of+the+alphaA+domain+generates+LFA-1/ICAM-1+catch+bonds.">Forcing switch from short- to intermediate- and long-lived states of the alphaA domain generates LFA-1/ICAM-1 catch bonds.</a> J. Biol. Chem. 285, 35967-35978 (2010).</li><li>Chien, Y. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Two+stage+cadherin+kinetics+require+multiple+extracellular+domains+but+not+the+cytoplasmic+region.">Two stage cadherin kinetics require multiple extracellular domains but not the cytoplasmic region.</a> J. Biol. Chem. 283, 1848-1856 (2008).</li><li>Huang, J., Edwards, L. J., Evavold, B. D., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Kinetics+of+MHC-CD8+interaction+at+the+T+cell+membrane.">Kinetics of MHC-CD8 interaction at the T cell membrane.</a> J. Immunol. 179, 7653-7662 (2007).</li><li>Wasserman, H. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=MHC+variant+peptide-mediated+anergy+of+encephalitogenic+T+cells+requires+SHP-1.">MHC variant peptide-mediated anergy of encephalitogenic T cells requires SHP-1.</a> J. Immunol. 181, 6843-6849 (2008).</li><li>Huang, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+kinetics+of+two-dimensional+TCR+and+pMHC+interactions+determine+T-cell+responsiveness.">The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness.</a> Nature. 464, 932-936 .</li><li>Sabatino, J. J., Huang, J., Zhu, C., Evavold, B. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=High+prevalence+of+low+affinity+peptide-MHC+II+tetramer-negative+effectors+during+polyclonal+CD4++T+cell+responses.">High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses.</a> J. Exp. Med. 208, 81-90 (2011).</li><li>Jiang, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Two-stage+cooperative+T+cell+receptor-peptide+major+histocompatibility+complex-CD8+trimolecular+interactions+amplify+antigen+discrimination.">Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination.</a> Immunity. 34, 13-23 (2011).</li><li>Spillmann, C. M., Lomakina, E., Waugh, R. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Neutrophil+adhesive+contact+dependence+on+impingement+force.">Neutrophil adhesive contact dependence on impingement force.</a> Biophys. J. 87, 4237-4245 (2004).</li><li>Zhu, C., Williams, T. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Modeling+concurrent+binding+of+multiple+molecular+species+in+cell+adhesion.">Modeling concurrent binding of multiple molecular species in cell adhesion.</a> Biophys. J. 79, 1850-1857 (2000).</li><li>Downey, G. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Retention+of+leukocytes+in+capillaries:+role+of+cell+size+and+deformability.">Retention of leukocytes in capillaries: role of cell size and deformability.</a> J. Appl. Physiol. 69, 1767-1778 (1990).</li><li>Li, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Affinity+and+kinetic+analysis+of+Fcgamma+receptor+IIIa+(CD16a)+binding+to+IgG+ligands.">Affinity and kinetic analysis of Fcgamma receptor IIIa (CD16a) binding to IgG ligands.</a> J. Biol. Chem. 282, 6210-6221 (2007).</li><li>Chen, W., Zarnitsyna, V. I., Sarangapani, K. K., Huang, J., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Measuring+Receptor-Ligand+Binding+Kinetics+on+Cell+Surfaces:+From+Adhesion+Frequency+to+Thermal+Fluctuation+Methods.">Measuring Receptor-Ligand Binding Kinetics on Cell Surfaces: From Adhesion Frequency to Thermal Fluctuation Methods.</a> Cell. Mol. Bioeng. 1, 276-288 (2008).</li><li>Thoumine, O., Kocian, P., Kottelat, A., Meister, J. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Short-term+binding+of+fibroblasts+to+fibronectin:+optical+tweezers+experiments+and+probabilistic+analysis.">Short-term binding of fibroblasts to fibronectin: optical tweezers experiments and probabilistic analysis.</a> Eur. Biophys. J. 29, 398-408 (2000).</li><li>Ounkomol, C., Xie, H., Dayton, P. A., Heinrich, V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Versatile+horizontal+force+probe+for+mechanical+tests+on+pipette-held+cells,+particles,+and+membrane+capsules.">Versatile horizontal force probe for mechanical tests on pipette-held cells, particles, and membrane capsules.</a> Biophys. J. 96, 1218-1231 (2009).</li><li>Piper, J. W., Swerlick, R. A., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Determining+force+dependence+of+two-dimensional+receptor-ligand+binding+affinity+by+centrifugation.">Determining force dependence of two-dimensional receptor-ligand binding affinity by centrifugation.</a> Biophys. J. 74, 492-513 (1998).</li><li>Li, P., Selvaraj, P., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Analysis+of+competition+binding+between+soluble+and+membrane-bound+ligands+for+cell+surface+receptors.">Analysis of competition binding between soluble and membrane-bound ligands for cell surface receptors.</a> Biophys. J. 77, 3394-3406 (1999).</li><li>Long, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Probabilistic+modeling+of+rosette+formation.">Probabilistic modeling of rosette formation.</a> Biophys. J. 91, 352-363 (2006).</li><li>Lou, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Flow-enhanced+adhesion+regulated+by+a+selectin+interdomain+hinge.">Flow-enhanced adhesion regulated by a selectin interdomain hinge.</a> J. Cell. Biol. 174, 1107-1117 (2006).</li><li>Yago, T., Zarnitsyna, V. I., Klopocki, A. G., McEver, R. P., Zhu, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transport+governs+flow-enhanced+cell+tethering+through+L-selectin+at+threshold+shear.">Transport governs flow-enhanced cell tethering through L-selectin at threshold shear.</a> Biophys. J. 92, 330-342 (2007).</li><li>Evans, E., Berk, D., Leung, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Detachment+of+agglutinin-bonded+red+blood+cells.+I.+Forces+to+rupture+molecular-point+attachments.">Detachment of agglutinin-bonded red blood cells. I. Forces to rupture molecular-point attachments.</a> Biophys. J. 59, 838-848 (1991).</li><li>Zarnitsyna, V. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Memory+in+receptor-ligand-mediated+cell+adhesion.">Memory in receptor-ligand-mediated cell adhesion.</a> Proc. Natl. Acad. Sci. U. S. A. 104, 18037-18042 (2007).</li></ol>

No conflicts of interest declared.

To successfully use the micropipette adhesion frequency assay one should consider several critical steps. First, make sure to record the specific interaction for the receptor-ligand system of interest. Nonspecific control measurements (cf. Fig. 3, 4) ensure the specificity. Ideally, nonspecific adhesion probabilities should be below 0.05 for all contact time durations and to have a significant difference between the specific and nonspecific adhesion probabilities for each time point. Different methods could be used to co...

<table border="1">
<tbody>
<tr>
<th>Name of the reagent</th>
<th>Company</th>
<th>Catalogue #</th>
<th>Comments</th>
</tr>
<tr>
<td>10x PBS</td>
<td>BioWhittaker</td>
<td>17-517Q</td>
<td>Dilute to 1x with deionized water prior to use</td>
</tr>
<tr>
<td>Vacutainer EDTA </td>
<td>BD</td>
<td>366643</td>
<td>RBCs isolation</td>
</tr>
<tr>
<td>10ML PK100</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Histopaque 1077</td>
<td>Sigma-Aldrich</td>
<td>10771</td>
<td>RBCs isolation</td>
</tr>
<tr>
<td>Adenine</td>
<td>Sigma-Aldrich</td>
<td>A2786</td>
<td>EAS-45 preparation</td>
</tr>
<tr>
<td>D-glucose (dextrose)</td>
<td>Sigma-Aldrich</td>
<td>G7528</td>
<td>EAS-45 preparation</td>
</tr>
<tr>
<td>D-Mannitol</td>
<td>Sigma-Aldrich</td>
<td>6360</td>
<td>EAS-45 preparation</td>
</tr>
<tr>
<td>Sodium Chloride (NaCl)</td>
<td>Sigma-Aldrich</td>
<td>S7653</td>
<td>EAS-45 preparation</td>
</tr>
<tr>
<td>Sodium Phosphate, Dibasic (Na&#x2082;HPO&#x2084;)</td>
<td>Fisher Scientific</td>
<td>S374</td>
<td>EAS-45 preparation</td>
</tr>
<tr>
<td>L-glutamine</td>
<td>Sigma-Aldrich</td>
<td>G5763</td>
<td>EAS-45 preparation</td>
</tr>
<tr>
<td>Biotin-X-NHS</td>
<td>Calbiochem</td>
<td>203188</td>
<td>RBCs biotinylation</td>
</tr>
<tr>
<td>Dimethylformamide (DMF)</td>
<td>Thermo Scientific</td>
<td>20673</td>
<td>RBCs biotinylation</td>
</tr>
<tr>
<td>Borate Buffer (0.1M)</td>
<td>Electron Microscopy Sciences</td>
<td>11455-90</td>
<td>RBCs biotinylation</td>
</tr>
<tr>
<td>Streptavidin</td>
<td>Thermo Scientific</td>
<td>21125</td>
<td>Ligand functionalizing</td>
</tr>
<tr>
<td>BSA</td>
<td>Sigma-Aldrich</td>
<td>A0336</td>
<td>Ligand functionalizing</td>
</tr>
<tr>
<td>Quantibrite PE Beads</td>
<td>BD Biosciences</td>
<td>340495</td>
<td>Density quantification</td>
</tr>
<tr>
<td>Flow cytometer</td>
<td>BD Immunocytometry Systems</td>
<td>BD LSR II</td>
<td>Density quantification</td>
</tr>
<tr>
<td>Capillary Tube
0.7-1.0mm x 30&quot;</td>
<td>Kimble Glass Inc.</td>
<td>46485-1</td>
<td>Micropipette pulling</td>
</tr>
<tr>
<td>Mineral Oil</td>
<td>Fisher Scientific</td>
<td>BP2629-1</td>
<td>Chamber assembly</td>
</tr>
<tr>
<td>Microscope Cover Glass</td>
<td>Fisher Scientific</td>
<td>12-544-G</td>
<td>Chamber assembly</td>
</tr>
<tr>
<td>PE &alpha;-human CD11a 
Clone HI 111 </td>
<td>eBioscience</td>
<td>12-0119-71</td>
<td>Reagent for Fig.1</td>
</tr>
<tr>
<td>PE anti-human CD54 </td>
<td>eBioscience</td>
<td>12-0549</td>
<td>Reagent for Fig.1</td>
</tr>
<tr>
<td>Mouse IgG1 Isotype Control PE</td>
<td>eBioscience</td>
<td>12-4714</td>
<td>Reagent for Fig.1</td>
</tr>
<tr>
<td>hydraulic micromanipulator</td>
<td>Narishige</td>
<td>MO-303</td>
<td>Micropipette system</td>
</tr>
<tr>
<td>Mechanical manipulator</td>
<td>Newport</td>
<td>461-xyz-m, SM-13, DM-13</td>
<td>Micropipette system</td>
</tr>
<tr>
<td>piezoelectric translator</td>
<td>Physik Instrumente</td>
<td>P-840</td>
<td>Micropipette system</td>
</tr>
<tr>
<td>LabVIEW</td>
<td>National Instruments</td>
<td>Version 8.6</td>
<td>Micropipette system</td>
</tr>
<tr>
<td>DAQ board</td>
<td>National Instruments</td>
<td>USB-6008</td>
<td>Micropipette system</td>
</tr>
<tr>
<td>Optical table</td>
<td>Kinetics Systems</td>
<td>5200 Series</td>
<td>Micropipette system</td>
</tr>
</tbody>
</table>

adhesion frequency assay for in situ kinetics analysis of cross-junctional molecular interactions at the cell-cell interface

The micropipette adhesion assay was developed in 1998 to measure two-dimensional (2D) receptor-ligand binding kinetics1. The assay uses a human red blood cell (RBC) as adhesion sensor and presenting cell for one of the interacting molecules. It employs micromanipulation to bring the RBC into contact with another cell that expresses the other interacting molecule with precisely controlled area and time to enable bond formation. The adhesion event is detected as RBC elongation upon pulling the two cells apart. By controlling the density of the ligands immobilized on the RBC surface, the probability of adhesion is kept in mid-range between 0 and 1. The adhesion probability is estimated from the frequency of adhesion events in a sequence of repeated contact cycles between the two cells for a given contact time. Varying the contact time generates a binding curve. Fitting a probabilistic model for receptor-ligand reaction kinetics1 to the binding curve returns the 2D affinity and off-rate.
The assay has been validated using interactions of Fc&gamma; receptors with IgG Fc1-6, selectins with glycoconjugate ligands6-9, integrins with ligands10-13, homotypical cadherin binding14, T cell receptor and coreceptor with peptide-major histocompatibility complexes15-19.
The method has been used to quantify regulations of 2D kinetics by biophysical factors, such as the membrane microtopology5, membrane anchor2, molecular orientation and length6, carrier stiffness9, curvature20, and impingement force20, as well as biochemical factors, such as modulators of the cytoskeleton and membrane microenvironment where the interacting molecules reside and the surface organization of these molecules15,17,19.
The method has also been used to study the concurrent binding of dual receptor-ligand species3,4, and trimolecular interactions19 using a modified model21.
The major advantage of the method is that it allows study of receptors in their native membrane environment. The results could be very different from those obtained using purified receptors17. It also allows study of the receptor-ligand interactions in a sub-second timescale with temporal resolution well beyond the typical biochemical methods.
To illustrate the micropipette adhesion frequency method, we show kinetics measurement of intercellular adhesion molecule 1 (ICAM-1) functionalized on RBCs binding to integrin &alpha;L&beta;2 on neutrophils with dimeric E-selectin in the solution to activate &alpha;L&beta;2.

Watch this Scientific Journal Video about Adhesion Frequency Assay for In Situ Kinetics Analysis of Cross-Junctional Molecular Interactions at the Cell-Cell Interface at JoVE.com

Adhesion Frequency Assay for In Situ Kinetics Analysis of Cross-Junctional Molecular Interactions at the Cell-Cell Interface

An adhesion frequency assay for measuring receptor-ligand interaction kinetics when both molecules are anchored on the surfaces of the interacting cells is described. This mechanically-based assay is exemplified using a micropipette-pressurized human red blood cell as adhesion sensor and integrin &alpha;L&beta;2 and intercellular adhesion molecule-1 as interacting receptors and ligands.

Adhesion Frequency Assay for In Situ Kinetics Analysis of Cross-Junctional Molecular Interactions at the Cell-Cell Interface

The micropipette adhesion assay was developed in 1998 to measure two-dimensional (2D) receptor-ligand binding kinetics1. The assay uses a human red blood ...

adhesion-frequency-assay-for-situ-kinetics-analysis-cross-junctional

Research

JoVE Journal

Bioengineering

14.9K Views.  Georgia Institute of Technology. An adhesion frequency assay for measuring receptor-ligand interaction kinetics when both molecules are anchored on the surfaces of the interacting cells is described. This mechanically-based assay is exemplified using a micropipette-pressurized human red blood cell as adhesion sensor and integrin αLβ2 and intercellular adhesion molecule-1 as interacting receptors and ligands.